Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, SoftGenetics, Sigma-Aldrich

Premium
Qiagen has launched QIAcube, a platform that automates the company’s consumable products. The platform includes more than 100 protocols for DNA, RNA, and protein sample processing, and can handle up to 12 samples per run.
 

 
SoftGenetics has released jelMarker, a software tool for converting slab gel TIFF, BIP, JPEG, and TXT files into a standard format for importing electrophoresis data into its GeneMarker software. The company said that it developed jelMarker “in response to the growing demand for software that can analyze fluorescence, chemiluminescence and autoradiography gel image files.”
 

 
Sigma-Aldrich has launched the GenomePlex Tissue Whole Genome Amplification kit. The kit includes all of the reagents needed for extraction and whole-genome amplification from as little as 0.1 mg of fresh, frozen, or formalin-fixed paraffin-embedded tissue. It can be used in a broad number of applications, including QPCR, microsatellite analysis, SNP analysis, comparative genomic hybridization, microarrays, and other genotyping analysis.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.